Received May 28, 2026
Reports are unverified and do not show that a vaccine caused an event. Full disclaimer
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RV5 | ROTAVIRUS (ROTATEQ) | MERCK & CO. INC. | 1 | 2155634 | OT |
Medical assistant confirmed that there were no symptomatic events reported by the patient's parents.; a patient (ages 20 weeks and 6 days) was given her first dose of ROTATEQ outside of the recommended 6 to 12 week starting dose indication; This spontaneous report was received from a medical assistant referring to a 20-weeks-old female patient. The patient's pertinent medical history, known drug reactions and allergies, and concomitant therapies were not reported. On 21-MAY-2026, the patient was vaccinated with rotavirus vaccine, live, oral, pentavalent (ROTATEQ) 2 mL, orally as prophylaxis (lot #2155634 has been verified to be valid, expiration date: 10-DEC-2026); outside of the recommended 6 to 12 week starting dose indication (Inappropriate schedule of product administration). Medical assistant confirmed that there were no symptomatic events reported by the patient's parents (No adverse event).